490
Participants
Start Date
January 14, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2032
fluzoparib monotherapy or combination therapy
patients with epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer who underwent fluzoparib monotherapy or combination therapy
RECRUITING
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
First Hospital of China Medical University
OTHER
Cancer Hospital of Xinjiang Medical University
UNKNOWN
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Qingyuan People's Hospital
OTHER
Zhejiang University
OTHER
Panzhihua Central Hospital
OTHER
Liangshan First People's Hospital
UNKNOWN
Guang'an People's Hospital
UNKNOWN
Affiliated Hospital of North Sichuan Medical College
OTHER
Cancer Hospital of Guizhou Province
OTHER
Guizhou International General Hospital
UNKNOWN
Yichang Central People's Hospital
OTHER
Wuhan Fourth Hospital
UNKNOWN
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Tongji Hospital
OTHER